Pediatrics Information Center
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Psychiatry Information Center
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
Neurology Information Center
Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
Hospital Medicine Information Center
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Mood Disorder Information Center
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Psoriasis Information Center
The effectiveness and safety profile of brodalumab during a period of 104 weeks in everyday practice are reported.
ADHD Information Center
Do women or girls with ADHD using hormonal contraceptives (HCs) have an increased risk for depression compared with HC users who do not have ADHD?
Psychiatry Information Center
A woman is evaluated by psychiatry on postpartum day 2 after staff noticed her talking to the mirror in her room and not showing affection to her newborn child. Case shows ethical decisions made when managing mental illness during pregnancy.
General Medicine
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Practice Management Information Center
California Attorney General Rob Bonta is taking 3 major drugmakers and 3 distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.